President and CEO Jay R. Luly to Retire by February 1, 2027
What happened
3 signals in this filing. Jay R. Luly, Ph.D., will retire as President and Chief Executive Officer by February 1, 2027, following 23 years of leadership.
Source
Extracted by Autobound
From the Signal API record- Signal
- SEC 8-K
What this signalsFilings often name leadership changes, deals and spending plans.
- Form
- 8-K
- Filed
- Nov 16, 2026
More SEC 8-K signals at other companies
- SEC 8-KAclaris Therapeutics, Inc.Aclaris Initiates Phase 2b ALPHA Trial of Modzatinib in Moderate-to-Severe Lichen PlanusSEC 8-K
- SEC 8-KAirjoule Technologies CorporationTimothy N. White Appointed to Board of Directors Succeeding Ajay Agrawal Effective November 12, 2026SEC 8-K
- SEC 8-KAMC Robotics CorporationRecorded $0.25 million non-recurring inventory impairment associated with Vietnam supply chain relocationSEC 8-K
The full record
From the Signal API recordDetails
- CIK
- 1177648
- Accession number
- 0001193125-26-463508
- Timeframe
- Next year
- Filing year
- 2026
- Fiscal year end
- 11/16
- Why it matters
- Full vendor review - highest priority
- Signal category
- Leadership
- Event
- ceoChange
Topics and mentions
Events in the filing
- CEO change
- Clinical milestone
- COO change
Tags
- ceoChange
- clinicalMilestone
- cooChange
Extraction
- Confidence
- High
- Relevance
- 95%
- Sentiment
- Neutral
- Detected
- Nov 17, 2026
- signal_type
sec-8k- signal_subtype
ceoChange
Use this data
Get every SEC 8-K signal for Enanta Pharmaceuticals, Inc. and the companies you sell to, in the tools you already use.
Ask Claude about it
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Enanta Pharmaceuticals, Inc. this week?”
Send it to your own tools
The Signal API returns SEC 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Try it free
Sign up and spend your free credits on the companies you sell to.
Start Free1,000 free credits
The API returns more than this page shows
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the API
Signal
signal_nameValue in the APIassociationValue in the API
Show the full JSONHide the full JSONThe record on this page and the API request
GET /v1/signals/1df1123b-be12-47b9-98f1-b85a323fa1e9 returns this record as JSON. POST /v1/companies/enrich returns every signal for enanta.com.
{
"signal_id": "1df1123b-be12-47b9-98f1-b85a323fa1e9",
"signal_type": "sec-8k",
"signal_subtype": "ceoChange",
"detected_at": "2026-11-17T07:03:13.241+00:00",
"company": {
"name": "Enanta Pharmaceuticals, Inc.",
"domain": "enanta.com"
},
"data": {
"detail": "Jay R. Luly, Ph.D., will retire as President and Chief Executive Officer by February 1, 2027, following 23 years of leadership. For sellers: Executive transitions often lead to strategic realignments and vendor re-evaluations.",
"metrics": {
"timeframe": "next_year"
},
"summary": "President and CEO Jay R. Luly to Retire by February 1, 2027",
"relevance": 0.95,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1177648/000119312526463508/enta-20261116.htm",
"filing_date": "2026-11-16",
"filing_year": 2026,
"fiscal_year_end": "11/16",
"sales_relevance": "Full vendor review - highest priority",
"signal_category": "leadership"
}
}
curl https://signals.autobound.ai/v1/signals/1df1123b-be12-47b9-98f1-b85a323fa1e9 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"enanta.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.